Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D MORROW

Showing results (51-60 of 173) with videos related to

Pageof 18
Sort By:
Drug News & Perspectives|December 24, 2004
F2-isoprostanes and the kidneyA K Salahudeen, J F Reckelhoff, J D Morrow, et al.
Archives of Dermatology|November 1, 1994
Release of markedly increased quantities of prostaglandin D2 from the skin in vivo in humans following the application of sorbic acidJ D Morrow, T A Minton, J A Awad, et al.
Advances in Experimental Medicine and Biology|January 1, 1997
Induction of prostaglandin endoperoxide synthase-1 (COX-1) in a human promonocytic cell line by treatment with the differentiating agent TPAC J Smith, J D Morrow, L J Roberts, et al.
Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis|May 4, 1999
Cryofiltration apheresis and plasma fractionation causing anaphylactoid reactions in patients receiving angiotensin converting enzyme inhibitorsG A Siami, F S Siami, J D Morrow, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 1, 1999
New developments in the isoprostane pathway: identification of novel highly reactive gamma-ketoaldehydes (isolevuglandins) and characterization of their protein adductsL J Roberts, R G Salomon, J D Morrow, et al.
The Journal of Biological Chemistry|August 10, 2000
Regulation of constitutive cyclooxygenase-2 expression in colon carcinoma cellsJ Shao, H Sheng, H Inoue, et al.
Southern Medical Journal|December 1, 1988
Eaton-Lambert syndrome in a patient with acute T cell lymphocytic leukemiaJ D Morrow, F A Manian, M E Clinton, et al.
Biochemical and Biophysical Research Communications|April 30, 1993
Differentiation of monocytoid THP-1 cells with phorbol ester induces expression of prostaglandin endoperoxide synthase-1 (COX-1)C J Smith, J D Morrow, L J Roberts, et al.
Gastroenterology Clinics of North America|June 1, 1996
Isoprostanes--prostaglandin-like compounds formed in vivo independently of cyclooxygenase: use as clinical indicators of oxidant damageJ A Awad, L J Roberts, R F Burk, et al.
The Journal of Biological Chemistry|May 1, 1999
Identification of extremely reactive gamma-ketoaldehydes (isolevuglandins) as products of the isoprostane pathway and characterization of their lysyl protein adductsC J Brame, R G Salomon, J D Morrow, et al.
Pageof 18

Showing results (51-60 of 173) with videos related to

Sort By:
Pageof 18
Drug News & Perspectives|December 24, 2004
F2-isoprostanes and the kidneyA K Salahudeen, J F Reckelhoff, J D Morrow, et al.
Archives of Dermatology|November 1, 1994
Release of markedly increased quantities of prostaglandin D2 from the skin in vivo in humans following the application of sorbic acidJ D Morrow, T A Minton, J A Awad, et al.
Advances in Experimental Medicine and Biology|January 1, 1997
Induction of prostaglandin endoperoxide synthase-1 (COX-1) in a human promonocytic cell line by treatment with the differentiating agent TPAC J Smith, J D Morrow, L J Roberts, et al.
Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis|May 4, 1999
Cryofiltration apheresis and plasma fractionation causing anaphylactoid reactions in patients receiving angiotensin converting enzyme inhibitorsG A Siami, F S Siami, J D Morrow, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 1, 1999
New developments in the isoprostane pathway: identification of novel highly reactive gamma-ketoaldehydes (isolevuglandins) and characterization of their protein adductsL J Roberts, R G Salomon, J D Morrow, et al.
The Journal of Biological Chemistry|August 10, 2000
Regulation of constitutive cyclooxygenase-2 expression in colon carcinoma cellsJ Shao, H Sheng, H Inoue, et al.
Southern Medical Journal|December 1, 1988
Eaton-Lambert syndrome in a patient with acute T cell lymphocytic leukemiaJ D Morrow, F A Manian, M E Clinton, et al.
Biochemical and Biophysical Research Communications|April 30, 1993
Differentiation of monocytoid THP-1 cells with phorbol ester induces expression of prostaglandin endoperoxide synthase-1 (COX-1)C J Smith, J D Morrow, L J Roberts, et al.
Gastroenterology Clinics of North America|June 1, 1996
Isoprostanes--prostaglandin-like compounds formed in vivo independently of cyclooxygenase: use as clinical indicators of oxidant damageJ A Awad, L J Roberts, R F Burk, et al.
The Journal of Biological Chemistry|May 1, 1999
Identification of extremely reactive gamma-ketoaldehydes (isolevuglandins) as products of the isoprostane pathway and characterization of their lysyl protein adductsC J Brame, R G Salomon, J D Morrow, et al.
Pageof 18